Bedaquiline
Sirturo (bedaquiline) is a small molecule pharmaceutical. Bedaquiline was first approved as Sirturo on 2012-12-28. It is used to treat multidrug-resistant tuberculosis and mycobacterium infections in the USA. It has been approved in Europe to treat multidrug-resistant tuberculosis. Sirturo's patent is valid until 2029-03-19 (FDA).
| Trade Name | Sirturo |
|---|---|
| Common Name | Bedaquiline |
| Indication | multidrug-resistant tuberculosis, mycobacterium infections |
| Drug Class | Antibiotics, diarylquinoline structure |
